Win- (3183.T) traded up 0.24 % during a 24 hours period ending at 09:53 PM Central Europe on Monday 26th. One Win- stock can currently be bought for about JPY 1,230 on popular exchanges. Current supply of Win- stocks is 27.5 mn. Win- has a current market capitalization of JPY 34.2 bn and approximately JPY 21.9 mn worth of Win- was traded on exchanges in the last 24 hours. Since last month end, Win- has traded -2.05 % down. Simple moving average of last 200 days is at JPY 1,303.77. The highest price of past 52 weeks was recorded at JPY 1,527 on 03/02/2026. 52 weeks low was at JPY 1,175 on 06/03/2026.

Here is how related stocks have performed in the past 24 hours:

  • Jdc (1887.T) traded flat 0 % and now trades at JPY 514. Jdc has a market capitalisation of JPY 40.8 bn. Current price/earnings ratio for Jdc is 7.08.

  • Yagi & (7460.T) traded up 2.12 % and now trades at JPY 1,731. Current market capitalisation for Yagi & is JPY 41.1 bn. Current price/earnings ratio for Yagi & is 11.54.

  • Value Hr (6078.T) traded up 0.8 % and now trades at JPY 1,514. Current market capitalisation for Value Hr is JPY 40.5 bn. Value Hr has a current price to earnings ratio of 54.56.

  • Adtec Plasma (6668.T) traded down -1.05 % and now trades at JPY 4,645. Current market capitalisation for Adtec Plasma is JPY 40.3 bn. Current price/earnings ratio for Adtec Plasma is 18.92.

  • Yushiro (5013.T) traded down -0.78 % and now trades at JPY 3,090. Yushiro has a market capitalisation of JPY 40.9 bn. Yushiro has a current price to earnings ratio of 10.28.

About Win-

WIN-Partners Co., Ltd. is a health care company operating in Japan that specializes in distributing medical devices primarily within that country. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; stent grafts, transcatheter heart valves, and mechanical heart valves. Additionally, they provide peripheral vascular stents, carotid artery stents, and neurovascular occlusion coils; and insulin pumps, X-ray angio systems, and magnetic resonance imaging equipment. This health care provider was founded in 1973 and has its main headquarters in Tokyo, Japan. You can find more information about the company and its offerings on their website at www.win-partners.co.jp , and they are listed on the Tokyo Stock Exchange. Their initial public offering took place on September 10, 2002.